Patent application number | Description | Published |
20090117575 | Detection Probe Acting by Molecular Recognition - The present invention relates to a detection probe acting by molecular recognition of a target sequence, comprising successively in the 5′-3′ direction:
| 05-07-2009 |
20090311688 | Novel Labeled oligonucleotide - The present invention relates to a labeled oligonucleotide comprising a first nucleotide segment and a second nucleotide segment, complementary to a target sequence, characterized in that it comprises a fluorophore, a quencher and at least one alpha-anomeric nucleoside. The invention also relates to the use of such an oligonucleotide and also to a process using such an oligonucleotide. | 12-17-2009 |
20100086976 | METHOD FOR DECONTAMINATING A SOLUTION WITH RESPECT TO UNWANTED NUCLEIC ACIDS - The present invention concerns a method for decontaminating a solution of any nucleic acid present in said solution, comprising the following steps:
| 04-08-2010 |
20100136538 | MARKING REAGENTS BEARING DIAZO AND NITRO FUNCTIONS, METHODS FOR THE SYNTHESIS OF SUCH REAGENTS AND METHODS FOR DETECTING BIOLOGICAL MOLECULES - The present invention relates to a labeling reagent of formula: | 06-03-2010 |
20100145014 | SYSTEM AND PROCESS FOR THE SYNTHESIS OF POLYMERS - The present invention relates to an automated polymer synthesis apparatus for synthesizing a polymer chain onto a solid substrates by sequentially adding polymer building blocks as well as to a method for synthesizing polymers on solid substrates by sequentially reacting polymer building blocks with reactive groups. The invention further relates to a biochip comprising a solid substrate with reactive groups where biomolecules are attached to and the remaining reactive groups are transformed into chemically inert species. | 06-10-2010 |
20110104762 | Detection probe acting by molecular recognition - The present invention relates to a detection probe acting by molecular recognition of a target sequence, comprising successively in the 5′-3′ direction:
| 05-05-2011 |
20110111514 | LABELLING REAGENTS HAVING A PYRIDINE NUCLEUS BEARING A DIAZOMETHYL FUNCTION, PROCESS FOR SYNTHESIS OF SUCH REAGENTS AND PROCESSES FOR DETECTION OF BIOLOGICAL MOLECULES - A process for synthesis of a labelling reagent, a process for the labelling of a biological molecule, a labelled biological molecule obtained by the process, a process for labelling and fragmentation of a single or double strand nucleic acid, a labelled nucleic acid capable of being obtained by the process, a kit for detection of a target nucleic acid containing a labelled nucleic acid, a solid support onto which is attached a reagent and a process for capture of nucleic acids. | 05-12-2011 |
20130253179 | Functionalization Processes and Reactants Used in Such Processes Using an Isatoic Anhydride or a Derivative Thereof, Biological Molecules Thus Treated and Kits - The present invention relates to a process of functionalising at least one ribonucleic acid (RNA) molecule which comprises the following steps:
| 09-26-2013 |
20140356870 | METHOD FOR TRANSCRIPTIONAL AMPLIFICATION OF NUCLEIC ACIDS COMBINING STEPS OF DIFFERENT TEMPERATURES - A method of transcriptional amplification includes: (a) obtaining a mixture by combining (i) a biological sample comprising nucleic acids, (ii) amplification primers, (iii) amplification reagents including enzymes required for amplification, and (iv) at least one polyol capable of stabilizing the enzymes required for amplification; (b) denaturing the nucleic acids by heating the mixture at a temperature above 41° C.; and (c) transcriptionally amplifying at least one target nucleic acid at a temperature above 41° C. when present in the mixture. | 12-04-2014 |
Patent application number | Description | Published |
20090192140 | IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed herein is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: | 07-30-2009 |
20100203012 | IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed herein is a compound of Formula 1: | 08-12-2010 |
20100221261 | IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I or II | 09-02-2010 |
20100292269 | BIR DOMAIN BINDING COMPOUNDS - The present invention is directed towards an isomer, an enantiomer, a diastereoisomer, or a tautomer of a pyrrolidine compound represented by Formula I: | 11-18-2010 |
20110117081 | FUNCTIONALIZED PYRROLIDINES AND USE THEREOF AS IAP INHIBITORS - A compound of Formula (1) or a salt thereof, methods for the preparation and use of such a compound, especially as an IAP inhibitor, and related compounds, compositions, and methods. | 05-19-2011 |
20110171171 | BRIDGED SECONDARY AMINES AND USE THEREOF AS IAP BIR DOMAIN BINDING COMPOUNDS - A compound of Formula 1.1A: 1.1A or salt thereof, as well as methods of making compounds of Formula 1.1A, methods of using compounds of Formula 1.1A to treat proliferative disorders such as cancer, and related compounds, composition, and methods. | 07-14-2011 |
20120009141 | FUNCTIONALIZED PYRROLIDINES AND USE THEREOF AS IAP INHIBITORS - A compound of Formula 1: or a salt thereof, and methods for the use thereof, especially as an IAP inhibitor, as well as related compounds, compositions, and methods. | 01-12-2012 |
20120141496 | IAP BIR DOMAIN BINDING COMPOUNDS - The present invention, according to several embodiments, comprises a compound represented by Formula I: | 06-07-2012 |
20120195915 | IAP BIR domain binding compounds - Disclosed herein is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I: | 08-02-2012 |
20130040892 | IAP BIR DOMAIN BINDING COMPOUNDS - A compound of Formula 1: (I) or salt thereof, as well as methods of making compounds of Formula 1, methods of using compounds of Formula 1 to treat proliferative disorders such as cancer, and related compounds, composition, and methods. | 02-14-2013 |
20130071411 | IAP BIR DOMAIN BINDING COMPOUNDS - Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I or II | 03-21-2013 |
20140045833 | Protein Kinase Inhibitors - The present invention relates to a novel family of inhibitors of protein kinases of Formula (1) wherein X is selected from CH2, O, S(0)n, or NR6; and process for their production and pharmaceutical compositions thereof. In particular, the present invention relates to inhibitors of the members of the Tec, Src, Btk and Lck protein kinase families. | 02-13-2014 |
20140336134 | IAP BIR Domain Binding Compounds - A compound of Formula I | 11-13-2014 |